Fulgent Genetics Inc.
Last updated September 27, 2026
Organization details
- Legal name
- Fulgent Genetics Inc.
- Former names
- Fulgent Diagnostics, Inc.
- Ownership
- Public
- Status
- Active
- SIC code
- 8071 — Services-Medical Laboratories
- Jurisdiction of incorporation
- Delaware
- Headquarters city
- EL Monte
- Headquarters state / province
- California
- Headquarters country
- United States
- Fiscal year end
- December
- Ticker symbol
- FLGT
- Primary stock exchange
- Nasdaq
Identifiers
- SEC CIK
- 0001674930
- EIN
- 81-2621304
Board of directors
-
Linda Marsh · DirectorSince 2023
-
Michael Nohaile · DirectorSince 2023
-
Ming Hsieh · Director · Chief Executive OfficerSince 2023
-
Regina E. Groves · DirectorSince 2023
Chief executives
Ming Hsieh
· Chief Executive Officer
Dates unknown
Director election results
Annual meeting of May 14, 2026. Support is votes for as a share of votes for and against (or withheld). Below 80% is a clear protest.
-
73.0%
-
77.6%
-
98.8%
Board connections
3 of this board's directors also sit on 3 other boards.
- via Linda Marsh
- via Regina E. Groves
- via Ming Hsieh
Insider trades
All notable trades →From SEC Forms 4 and 5. Open-market purchases and sales are highlighted; grants, option exercises and shares withheld for tax are routine.
- Bought, last 12 months
- $0
- 0 purchases by 0 insiders
- Sold, last 12 months
- $677,604
- 15 sales by 2 insiders
| Date | Insider | Transaction | Shares | Price | Value |
|---|---|---|---|---|---|
| Sep 2, 2026 | Gao Hanlin Officer (Chief Scientific Officer) | Open-market sale | −1,673 | $19.66 | $32,885 |
| Sep 2, 2026 | Xie Jian Officer (President and COO) | Open-market sale | −2,127 | $19.66 | $41,809 |
| Sep 1, 2026 | Paul Kim Officer (CFO and Treasurer) | Shares withheld for tax | −2,087 | $19.59 | $40,884 |
| Sep 1, 2026 | Ming Hsieh Director, Officer (Chief Executive Officer), 10% owner | Shares withheld for tax | −4,392 | $19.59 | $86,039 |
| Aug 27, 2026 | Gao Hanlin Officer (Chief Scientific Officer) | Open-market sale | −939 | $19.91 | $18,691 |
| Aug 27, 2026 | Xie Jian Officer (President and COO) | Open-market sale | −1,193 | $19.91 | $23,747 |
| Aug 26, 2026 | Paul Kim Officer (CFO and Treasurer) | Shares withheld for tax | −1,168 | $19.81 | $23,138 |
| Aug 26, 2026 | Ming Hsieh Director, Officer (Chief Executive Officer), 10% owner | Shares withheld for tax | −2,949 | $19.81 | $58,420 |
| Jul 26, 2026 | Gao Hanlin Officer (Chief Scientific Officer) | Shares withheld for tax | −1,645 | $19.67 | $32,357 |
| Jul 26, 2026 | Xie Jian Officer (President and COO) | Shares withheld for tax | −4,361 | $19.67 | $85,781 |
| Jul 26, 2026 | Paul Kim Officer (CFO and Treasurer) | Shares withheld for tax | −2,747 | $19.67 | $54,033 |
| Jun 2, 2026 | Xie Jian Officer (President and COO) | Open-market sale | −2,146 | $17.89 | $38,392 |
| Jun 2, 2026 | Gao Hanlin Officer (Chief Scientific Officer) | Open-market sale | −1,688 | $17.89 | $30,198 |
| Jun 1, 2026 | Paul Kim Officer (CFO and Treasurer) | Shares withheld for tax | −2,087 | $18.09 | $37,754 |
| Jun 1, 2026 | Ming Hsieh Director, Officer (Chief Executive Officer), 10% owner | Shares withheld for tax | −4,392 | $18.09 | $79,451 |
Reviews (0)
Sign in to write a review.
No reviews yet. Be the first to write one.